Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials

Tanghetti Emil A.; Werschler William P.; Lain Terry; Guenin Eric; Martin Gina; Pillai Radhakrishnan

首页> 外文期刊>Journal of drugs in dermatology: JDD >Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials

【24h】

Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials

机译：TaZarotene 0.045％洗剂是一次性治疗中度至严重的痤疮：两阶段3试验结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Tazarotene has been extensively studied in clinical trials and is widely used to treat acne vulgaris (acne), with data suggesting that is one of the most potent topical retinoids. Irritation from the cream, foam, and gel formulations has limited its use in clinical practice.

机译：背景：在临床试验中广泛研究了塔拉塔琳，广泛用于治疗痤疮（痤疮），数据表明是最有效的局部视网膜醇之一。来自奶油，泡沫和凝胶配方的刺激，限制了其在临床实践中的用途。

著录项

来源
《Journal of drugs in dermatology: JDD》 |2020年第1期|共8页
作者
Tanghetti Emil A.; Werschler William P.; Lain Terry; Guenin Eric; Martin Gina; Pillai Radhakrishnan;
展开▼
作者单位

Ctr Dermatol &

Laser Surg Sacramento CA 95819 USA;

Univ Washington Sch Med Seattle WA USA;

Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;

Ortho Dermatol Bridgewater NJ USA;

Bausch Hlth Amer Inc Petaluma CA USA;

Bausch Hlth Amer Inc Petaluma CA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials [J] . Tanghetti Emil A., Werschler William P., Lain Terry, Journal of drugs in dermatology: JDD . 2020,第1期

机译：TaZarotene 0.045％洗剂是一次性治疗中度至严重的痤疮：两阶段3试验结果
2. Tazarotene 0.045% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in Adult Males [J] . Cook-Bolden Fran E., Gold Michael H., Guenin Eric Journal of drugs in dermatology: JDD . 2020,第1期

机译：Tazarotene 0.045％乳液曾经每日治疗成年男性中度至严重的痤疮紫色
3. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Compare the Safety and Efficacy of a Novel Tazarotene 0.045% Lotion and Tazarotene 0.1% Cream in the Treatment of Moderate-to-Severe Acne Vulgaris [J] . Tanghetti Emil A., Kircik Leon H., Green Lawrence J., Journal of drugs in dermatology: JDD . 2019,第6期

机译：2阶段，多中心，双盲，随机，车辆控制的临床研究，比较新的塔拉替烯0.045％乳液和达拉替烯0.1％乳膏的安全性和功效治疗中度至严重的痤疮
4. Comparative study of oral administration of Sacha Inchi oil extraction with erythromycin versus oral erythromycin on the treatment of Acne Vulgaris [C] . Piraphol Suthiphasil, Jarasphol Rintha, Thamthiwat Nararatwanchai, International Conference on Digital Arts, Media and Technology . 2018

机译：红霉素与口服红霉素口服佐茶印加油提取物治疗寻常型痤疮的比较研究
5. Omega-3 Fatty Acid Supplementation: A Potential Treatment for Acne Vulgaris in Pregnant Women [D] . Fallahi, Parisa. 2020

机译：Omega-3脂肪酸补充剂：孕妇痤疮痤疮的潜在治疗方法
6. Tazarotene 0.045 Lotion for Moderate-to-Severe Acne in Male and Female Participants: A Phase II Post-hoc Analysis [O] . Hilary E. Baldwin, Lawrence J. Green, Leon Kircik, 2021

机译：TaZarotene在男性和女性参与者中适中对严重痤疮的0.045％乳液：HOC分析后II期

Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials

摘要

著录项

相似文献

相关主题

期刊订阅